2015 HRS Expert Consensus Statement on Remote Interrogation and Monitoring for Cardiovascular Electronic Implantable Devices

May 13, 2015—The current document is developed from the foundations established by the 2008 HRS Consensus Statement as well as the 2012 International Society for Holter and Noninvasive Electrocardiography and European Heart Rhythm Association’s Expert Consensus Statement on Remote Monitoring of CIEDs. The goals of follow-up, definition of hardware, and personnel remain the same and will not be covered in this document except where evolution of remote technologies and responsibilities has occurred. The current document provides new recommendations based on data published since 2008, endorsing the need to maintain consistent follow-up and outlining the limitations of strictly in-person methods.

 This document was reaffirmed on October 21, 2020, and will be formally assessed by October 2025.

Device Therapy

Cardiovascular electronic implantable devices (CIEDs) have evolved significantly since the publication of the 2008 Heart Rhythm Society HRS Consensus Statement outlining recommended monitoring strategies. Novel embedded technologies have created the ability for devices to monitor their own function, record arrhythmias and other physiological parameters and to communicate this information to health care providers without active participation of the patient. CIEDs with wireless remote monitoring capabilities stand at the forefront of a new class of medical devices that will unobtrusively acquire vital data outside of the boundaries of health care facilities and seamlessly transmit the information back to health care providers. This document focuses on implantable devices for management of heart rhythm disorders.

 Visit the HRS Learning Center to access a webinar on the 2015 HRS Expert Consensus Statement on Remote Interrogation and Monitoring for CIEDs.

The webinar summarizes the key clinical trials highlighting the superiority of remote monitoring and presents the new paradigm for managing CIED patients with continuous remote monitoring and event-triggered in-person evaluations.